Ginkgo Bioworks Investors Get Final OK Of $17.8M Settlement
By Emilie Ruscoe · December 16, 2024, 10:08 PM EST
Investors in biotech company Ginkgo Bioworks Holdings Inc. have gotten final approval for their $17.75 million deal to end proposed class action claims that the company and its leaders distorted Ginkgo's...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login